Guido Bonati is the new Chief Technology Officer and Head of Research & Development at FISBA AG

Guido Bonati, Head of R&D and CTO at FISBA AG since July 2020 Foto: FISBA

He structures the services required of R&D with the resources, ideas and potential and deploys efficient teams to successfully handle customer projects.

Guido Bonati was awarded a PhD in mechanical engineering, specializing in laser technology and design, at RWTH Aachen University in North Rhine-Westphalia, Germany.

He has worked in management positions all over the world for various companies in the optical industry, including in the fields of laser technology and optics, for over 25 years.

In his new position at FISBA, he can rely on his experience and in-depth knowledge in the development, production and business development fields.

Guido Bonati succeeds Christian Zellweger, who has taken up a new challenge within the company as its COO.

About FISBA Since 1957, FISBA has been supplying customers in the photonics sector with the industry’s largest range of design and manufacturing capacities for optical components and systems. Highly specialized teams satisfy the complex requirements of customers from the strictly regulated life sciences, defense and aerospace, industrial manufacturing and material processing fields and help world-leading brands fulfill their market potential. FISBA's services, which are centered on its customers, range from concept design through support in device development to engineering, supply-chain optimization and assembly. Our specially equipped branch offices that meet the strict market requirements while protecting our customers' intellectual property are ready to fulfill this purpose. FISBA runs operations at sites in Switzerland, Germany, USA and China.

Media contact
Birgit Rauch
Head of Corporate Marketing Communication
media@fisba.com

www.fisba.com

Media Contact

Birgit Rauch FISBA AG

All latest news from the category: Corporate News

Back to home

Comments (0)

Write a comment

Newest articles

Pancreatic cancer’s cellular amnesia

Things aren’t always as they seem. Take pancreatic cancer, for example. In up to one in 10 cases, researchers have documented a peculiar characteristic. Some of the pancreatic cells appear…

Innovative Polymer Wound Dressings for Painless and Residue-Free Removal

A new approach enables dressings that adhere firmly to the skin at body temperature, but can be removed easily and painlessly in combination with a cold pack. The dressing adheres…

SETI Institute launches groundbreaking technosignature science and technology

Application deadline for grants is July 15, 2024. The SETI Institute is announcing the launch of a pioneering grants program dedicated to advancing technosignature science. This first-of-its-kind initiative aims to…

Partners & Sponsors